Why is Amerise BioScie falling/rising?
2025-11-08 00:04:01As of 07-Nov, Amerise Biosciences Ltd is experiencing a decline in its stock price, currently at 0.61, which reflects a decrease of 0.04 or 6.15%. The stock has underperformed its sector by 7.67% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 29.59% compared to the 5-day average. Over the past year, the stock has seen a substantial decline of 44.55%, while its year-to-date performance shows a decrease of 49.59%. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement. In the broader market context, Amerise Biosciences Ltd's short-term performance over the past week shows a decline of 3.17%, while the benchmark Sensex has only decreased by 0.86%. This indicates that the stoc...
Read MoreHow has been the historical performance of Amerise BioScie?
2025-11-06 23:03:29Answer: The historical performance of Amerise BioScie shows a trend of minimal activity and fluctuating financial metrics over the years, with net sales consistently at zero from March 2020 to March 2025. Other operating income peaked at 9.01 crore in March 2022 but has since declined to 0.19 crore in March 2025. Total operating income followed a similar pattern, dropping from 9.01 crore in March 2022 to 0.19 crore in March 2025. The company reported total expenditure excluding depreciation of 0.18 crore in March 2025, which is significantly lower than the 9.03 crore recorded in March 2022. Operating profit (PBDIT) showed a recovery to 0.01 crore in March 2025 from a loss of 0.34 crore in March 2021, but overall profitability remains weak, with profit after tax at 0.01 crore in March 2025 compared to a profit of 0.55 crore in March 2022. The balance sheet reflects total liabilities of 8.46 crore in March 20...
Read MoreWhen is the next results date for Amerise BioScie?
2025-10-31 23:17:14Amerise BioScie is scheduled to declare its results on November 5, 2025....
Read MoreWhy is Amerise BioScie falling/rising?
2025-10-29 01:45:06As of 28-Oct, Amerise Biosciences Ltd is experiencing a price increase, currently at 0.66, with a change of 0.01 or 1.54% up. The stock has shown strong performance recently, gaining 20% over the past week and outperforming its sector by 1.8% today. However, despite this recent uptick, the stock's year-to-date performance remains significantly negative at -45.45%. Additionally, while the stock is currently above its 5-day and 20-day moving averages, it is still below its longer-term moving averages, indicating mixed momentum. Notably, there has been a decline in investor participation, with delivery volume dropping by 29.68% compared to the 5-day average, which may raise concerns about the sustainability of the recent gains. In the broader market context, Amerise Biosciences' short-term performance of +20.00% over the past week contrasts sharply with the Sensex, which has only increased by 0.24% in the sam...
Read MoreWhy is Amerise BioScie falling/rising?
2025-10-28 22:51:23As of 27-Oct, Amerise Biosciences Ltd is experiencing a price increase, currently at 0.65, which reflects a rise of 0.04 or 6.56%. The stock has shown strong performance recently, with a consecutive gain over the last three days and an impressive return of 18.18% over the past week. However, despite this short-term success, the stock has underperformed significantly on a year-to-date basis, down 46.28%, and over the last three years, it has declined by 38.68%. Additionally, while the stock is currently outperforming its sector by 6.28%, there has been a notable decrease in investor participation, with delivery volume dropping by 54.98% compared to the five-day average. Broader Market Context: In comparison to the benchmark Sensex, which has gained 0.49% over the past week, Amerise Biosciences Ltd's short-term performance is considerably stronger. The stock's recent gains contrast sharply with its long-term...
Read MoreWhy is Amerise BioScie falling/rising?
2025-10-24 23:46:03As of 24-Oct, Amerise Biosciences Ltd is experiencing a price increase, currently at 0.61, reflecting a change of 0.03 or 5.17% upward. The stock has shown a positive performance today, outperforming its sector by 5.45% and has been on a consecutive gain for the last two days, accumulating a total return of 10.91% during this period. However, it is important to note that the stock's performance over the past month has been negative, with a decline of 7.58%, and a year-to-date drop of 49.59%. The stock is currently trading higher than its 5-day moving average but lower than its longer-term moving averages, indicating mixed momentum. Additionally, there has been a significant decrease in investor participation, with delivery volume falling by 37.82% against the 5-day average, which could suggest waning interest despite the recent price increase. In the broader market context, Amerise Biosciences Ltd has outp...
Read MoreWhy is Amerise BioScie falling/rising?
2025-10-17 23:22:19As of 17-Oct, Amerise Biosciences Ltd's stock price is currently at 0.57, reflecting a decline of 0.03 or 5.0%. The stock has recently hit a new 52-week low of Rs.0.56 and has been on a downward trend, having fallen for the last six consecutive days, resulting in a total drop of 12.31% during this period. Additionally, the stock has underperformed its sector by 4.96% today. Over the past week, Amerise Biosciences has seen a significant decline of 10.94%, and its year-to-date performance shows a staggering drop of 52.89%. The stock is also trading below its moving averages across various time frames, indicating a bearish trend. Furthermore, investor participation has decreased, with delivery volume dropping by 41.64% compared to the five-day average, suggesting a lack of confidence among investors. Broader Market Context: In contrast to Amerise Biosciences' poor performance, the benchmark Sensex has shown p...
Read MoreWhy is Amerise BioScie falling/rising?
2025-10-15 23:34:09As of 15-Oct, Amerise Biosciences Ltd is experiencing a decline in its stock price, currently at Rs. 0.61, which reflects a decrease of Rs. 0.01 or 1.61%. The stock has hit a new 52-week low today and has been on a downward trend, having fallen consecutively for the last four days, resulting in a total decline of 6.15% over that period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating persistent weakness. Furthermore, investor participation has decreased, with delivery volume dropping by 26.6% compared to the 5-day average, suggesting a lack of interest or confidence among investors. In the broader market context, the Sensex has shown a positive return of 1.02% over the past week, contrasting sharply with Amerise Biosciences' 6.15% decline during the same period. This underperformance is further highlighted by the fact that the finance/NBF...
Read MoreWhy is Amerise BioScie falling/rising?
2025-09-24 23:19:50As of 24-Sep, Amerise Biosciences Ltd is currently priced at Rs. 0.66, showing no change (0.00%). The stock has hit a new 52-week low today, indicating a downward trend. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a persistent decline in its price. Over the past week, the stock has decreased by 10.81%, and it has seen a significant drop of 45.45% year-to-date. However, there has been a notable increase in investor participation, with delivery volume rising by 828.18% against the 5-day average, indicating some interest despite the overall negative performance. There are no positive or negative factors available to further explain the stock's recent movement. Broader market context shows that while Amerise Biosciences has been declining, the benchmark Sensex has only fallen by 1.18% over the past week and has gained 4.58% year-to-date. This stark contra...
Read MoreBoard Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 5Th November 2025.
05-Nov-2025 | Source : BSEPursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Wednesday 05th November 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and half year ended as on 30th September 2025. The board meeting commented at 02:45 PM and concluded at 3.15 PM Please take the above intimation in your records. Thanking You.
Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
05-Nov-2025 | Source : BSEPFA
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting
30-Oct-2025 | Source : BSEAmerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 inter alia to consider and approve PFA
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






